Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 501637882

Medchemexpress LLC Cabozantinib (Standard) | 849217-68-1 | 99.9% | 100 MG
SDP

Catalog No. 501637882
Encompass_Preferred

Cabozantinib is a potent and orally active inhibitor of VEGFR2 and MET. It also strongly inhibits KIT, RET, AXL, TIE2, and FLT3. Cabozantinib exhibits antiangiogenic activity, disrupting tumor vasculature and promoting apoptosis in tumor and endothelial cells.

  • Potent and orally active inhibitor
  • Inhibits VEGFR2 and MET
  • Strongly inhibits KIT, RET, AXL, TIE2, and FLT3
  • Exhibits antiangiogenic activity
  • Disrupts tumor vasculature
  • Promotes apoptosis in tumor and endothelial cells

Catalog No. 50-163-7882 Supplier Medchemexpress LLC Supplier No. HY13016100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Cabozantinib is a potent and orally active inhibitor of VEGFR2 and MET. It also strongly inhibits KIT, RET, AXL, TIE2, and FLT3. Cabozantinib exhibits antiangiogenic activity, disrupting tumor vasculature and promoting apoptosis in tumor and endothelial cells.

  • Potent and orally active inhibitor
  • Inhibits VEGFR2 and MET
  • Strongly inhibits KIT, RET, AXL, TIE2, and FLT3
  • Exhibits antiangiogenic activity
  • Disrupts tumor vasculature
  • Promotes apoptosis in tumor and endothelial cells

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.